195 related articles for article (PubMed ID: 17920283)
1. Increased metabolism in the R6/2 mouse model of Huntington's disease.
van der Burg JM; Bacos K; Wood NI; Lindqvist A; Wierup N; Woodman B; Wamsteeker JI; Smith R; Deierborg T; Kuhar MJ; Bates GP; Mulder H; Erlanson-Albertsson C; Morton AJ; Brundin P; Petersén A; Björkqvist M
Neurobiol Dis; 2008 Jan; 29(1):41-51. PubMed ID: 17920283
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
[TBL] [Abstract][Full Text] [Related]
3. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
[TBL] [Abstract][Full Text] [Related]
4. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
5. An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease.
Zarringhalam K; Ka M; Kook YH; Terranova JI; Suh Y; King OD; Um M
Behav Brain Res; 2012 Apr; 229(1):216-25. PubMed ID: 22266926
[TBL] [Abstract][Full Text] [Related]
6. Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease.
Dai Y; Dudek NL; Li Q; Fowler SC; Muma NA
J Neurosci; 2009 Sep; 29(37):11550-9. PubMed ID: 19759302
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.
Fisher SP; Black SW; Schwartz MD; Wilk AJ; Chen TM; Lincoln WU; Liu HW; Kilduff TS; Morairty SR
Brain; 2013 Jul; 136(Pt 7):2159-72. PubMed ID: 23801738
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
[TBL] [Abstract][Full Text] [Related]
9. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing.
Hickey MA; Gallant K; Gross GG; Levine MS; Chesselet MF
Neurobiol Dis; 2005 Oct; 20(1):1-11. PubMed ID: 16137562
[TBL] [Abstract][Full Text] [Related]
10. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease.
Ciamei A; Morton AJ
Neurobiol Learn Mem; 2009 Oct; 92(3):417-28. PubMed ID: 19524696
[TBL] [Abstract][Full Text] [Related]
11. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
Dufour BD; McBride JL
Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424
[TBL] [Abstract][Full Text] [Related]
12. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH
Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023
[TBL] [Abstract][Full Text] [Related]
13. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.
Yhnell E; Dunnett SB; Brooks SP
J Huntingtons Dis; 2016 May; 5(2):149-61. PubMed ID: 27258586
[TBL] [Abstract][Full Text] [Related]
14. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
Mo C; Renoir T; Hannan AJ
Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
[TBL] [Abstract][Full Text] [Related]
16. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
Pallier PN; Drew CJ; Morton AJ
Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
[TBL] [Abstract][Full Text] [Related]
17. Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6/1 mouse model of Huntington's disease.
Batcha AH; Greferath U; Jobling AI; Vessey KA; Ward MM; Nithianantharajah J; Hannan AJ; Kalloniatis M; Fletcher EL
Neurobiol Dis; 2012 Mar; 45(3):887-96. PubMed ID: 22198376
[TBL] [Abstract][Full Text] [Related]
18. Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease.
Fowler SC; Miller BR; Gaither TW; Johnson MA; Rebec GV
Behav Brain Res; 2009 Aug; 202(1):130-7. PubMed ID: 19447289
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.
Sathyasaikumar KV; Stachowski EK; Amori L; Guidetti P; Muchowski PJ; Schwarcz R
J Neurochem; 2010 Jun; 113(6):1416-25. PubMed ID: 20236387
[TBL] [Abstract][Full Text] [Related]
20. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.
Ruskin DN; Ross JL; Kawamura M; Ruiz TL; Geiger JD; Masino SA
Physiol Behav; 2011 Jul; 103(5):501-7. PubMed ID: 21501628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
